Squarepoint’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-113,607
| Closed | -$93.7K | – | 4782 |
|
|
2025
Q1 | $93.7K | Buy |
113,607
+15,187
| +15% | +$14.6K | ﹤0.01% | 4235 |
|
|
2024
Q4 | $93.5K | Buy |
+98,420
| New | +$92.9K | ﹤0.01% | 4712 |
|
|
2024
Q2 | – | Sell |
-107,754
| Closed | -$140K | – | 4379 |
|
|
2024
Q1 | $140K | Sell |
107,754
-45,668
| -30% | -$52.1K | ﹤0.01% | 3722 |
|
|
2023
Q4 | $192K | Buy |
153,422
+18,539
| +14% | +$20.5K | ﹤0.01% | 3611 |
|
|
2023
Q3 | $175K | Sell |
134,883
-90,777
| -40% | -$147K | ﹤0.01% | 3451 |
|
|
2023
Q2 | $388K | Buy |
225,660
+179,572
| +390% | +$285K | ﹤0.01% | 2799 |
|
|
2023
Q1 | $67.3K | Buy |
46,088
+15,870
| +53% | +$30.4K | ﹤0.01% | 3025 |
|
|
2022
Q4 | $49K | Buy |
+30,218
| New | +$69.6K | ﹤0.01% | 3057 |
|
|
2021
Q3 | – | Sell |
-28,137
| Closed | -$674K | – | 3186 |
|
|
2021
Q2 | $674K | Buy |
+28,137
| New | +$712K | ﹤0.01% | 1928 |
|
Squarepoint's KRON Position: Q2 2025 in Review
Squarepoint sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 113,607 shares — an estimated $93.7K sold.
Squarepoint first reported a position in KRON in Q2 2021 and held it in 9 quarters. The position peaked at $674K in Q2 2021. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.
- Squarepoint reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
- Squarepoint sold 113,607 Kronos Bio shares in Q2 2025, an estimated $93.7K.
- Squarepoint first reported a position in Kronos Bio in Q2 2021 and held it in 9 quarters.
- Squarepoint's Kronos Bio position peaked at $674K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.
Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.